July 7, 2011 -
PRLog -- Biomiga Diagnostics , a provider of rapid diagnostic testing solutions, announced today that it has signed purchasing agreement for certain products with Runbio Biotech Co., LTD, a Canadian sponsored biotechnology company that offers a wide range of in vitro rapid diagnostic testing kits and materials. Runbio’s product line is composed of four major product groups including fertility tests, tests for drugs of abuse, infectious diseases tests and tumor markers tests. Biomiga Diagnostics’
mission is to transform healthcare by providing patients and providers with quantitative and rapid point-of-care tests making personalized medicine a reality. This agreement with Runbio with strengthen and complement Biomiga Diagnostic’s product portfolio.
For additional information, please contact
Stephen Shi, PhD
Biomiga Diagnostics
info@biomigadiagnostics.com